论文部分内容阅读
目的探索建立行之有效的医院科技成果的经济效益评估方法体系。方法向北京市属医院征集重点产业转化类成果,利用“风险修正型现值收益法”模型(risk-adjusted net present value,rNPV)进行估值研究。结果共征集来自8家市属医院的14项成果,涉及化学药品、中药等5个产品领域,估值结果显示,各成果估值均符合当下技术市场行情相匹配的价值区间要求,因技术成熟度存在差异,其中1项成果偏向价值区间上限,5项偏下限,8项位于中线水平。结论 rNPV模型能够综合考量成果各项风险要素对估值结果的影响力,可以相对准确地对医院科技成果进行估值,具有较强的实践意义。
Objective To explore the establishment of an effective evaluation system of economic benefits of scientific and technological achievements of hospitals. Methods A series of key industry transformational outcomes were collected from Beijing Municipal Hospital and evaluated using the “risk-adjusted net present value” (rNPV) model. Results A total of 14 results from 8 municipal hospitals were collected, covering 5 product areas including chemical products and traditional Chinese medicine. The valuation results show that all the results are in line with the current value of the technology market matching the value of the interval required for the technology is mature There are differences in degrees, of which one results tend to the upper limit of the value range, 5 partial lower limit, 8 in the midline level. Conclusion The rNPV model can comprehensively consider the impact of various risk factors on the valuation results, and can accurately evaluate the scientific and technological achievements of the hospital, which has strong practical significance.